- 全部删除
您的购物车当前为空
PD-L1-IN-3 是一种具有选择性和高效性的 PD-1/PD-L1 抑制剂,具有抗肿瘤活性,通过阻止 PD-1 与 PD-L1 结合,从而阻断 PD-1 的信号传导发挥作用。PD-L1-IN-3 可用于研究肿瘤和免疫疾病。


为众多的药物研发团队赋能,
让新药发现更简单!
PD-L1-IN-3 是一种具有选择性和高效性的 PD-1/PD-L1 抑制剂,具有抗肿瘤活性,通过阻止 PD-1 与 PD-L1 结合,从而阻断 PD-1 的信号传导发挥作用。PD-L1-IN-3 可用于研究肿瘤和免疫疾病。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 898 | In stock | |
| 5 mg | ¥ 2,230 | In stock | |
| 10 mg | ¥ 3,560 | In stock | |
| 25 mg | ¥ 5,690 | In stock | |
| 50 mg | ¥ 7,690 | In stock | |
| 100 mg | ¥ 9,870 | In stock | |
| 200 mg | ¥ 13,800 | In stock |
PD-L1-IN-3 相关产品
| 产品描述 | PD-L1-IN-3 is a selective and potent PD-1/PD-L1 inhibitor with antitumor activity that blocks PD-1 signaling by preventing PD-1 from binding to PD-L1.PD-L1-IN-3 is used in the study of neoplasms and immune diseases. |
| 体外活性 | 在 Jurkat 细胞中,PD-L1-IN-3(0.01-100 μM;40分钟)的观察到的半最大效应浓度(EC50)值为 2.70 μM。 |
| 体内活性 | 在 PD-L1+/−(H358和ES2)肿瘤中,观察到 PD-L1-IN-3(0.01-100 μM;孵育期)在 PD-L1+ H358 肿瘤中的摄取量比野生型对照组高 40%-55%。然而,对于 ES2 肿瘤样本,未能区分野生型和基因敲除型[1]。 |
| 分子量 | 373.85 |
| 分子式 | C19H15ClFN2OS |
| CAS No. | 2953044-29-4 |
| Smiles | [Cl].N#CC1=C(OCC2=CC=C(C=C2)CN)SC=C1C=3C=CC(F)=CC3 |
| 密度 | no data available |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 100 mg/mL (267.49 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容